SCHEMBL10508102

SCHEMBL10508102

CCN(CCOc1ccc(C)cc1)CCOc1ccc(-n2ccnc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 10/20 0.70
CYP2C9 P11712 10/20 0.70
CYP1A2 P05177 7/20 0.70
CYP2C19 P33261 6/20 0.70
CYP3A4 P08684 8/20 0.67
CYP19A1 P11511 1/20 0.67
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA9 Q16790 2/20 0.55
QPCT Q16769 1/20 0.51
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10510793 0.99 CYP2D6 (0.68) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL7068561 0.92 CYP2D6 (0.77) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL18746335 0.87 CYP2D6 (0.74) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL10575923 0.82 CYP2D6 (0.76) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL14129849 0.82 CYP2D6 (1.00) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL14129854 0.81 CYP2D6 (1.00) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL14129968 0.79 CYP2D6 (1.00) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL10511254 0.79 CYP2D6 (0.64) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL8780938 0.79 CYP2D6 (0.55) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4
SCHEMBL6573617 0.78 CYP2D6 (0.72) CYP2D6CYP2C9CYP1A2CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4851526-A ANTIARRYTHMIA, HYPOTENSIVE, ANTIISCHEMIC SCHERING A.G. (DE) 1989-07-25 US disclosed
EP-0306440-A2 1-(4-substituted phenyl)-1H-imidazoles as cardiovascular agents SCHERING AKTIENGESELLSCHAFT (DE) 1989-03-08 EP disclosed